Unique mechanism of action for escitalopram: does it hold the promise?-Reference-Cited by-同舟云学术

Unique mechanism of action for escitalopram: does it hold the promise?

Published:2004-09 Issue:sup1 Volume:8 Page:15-18
ISSN:1365-1501
Container-title:International Journal of Psychiatry in Clinical Practice
language:en
Short-container-title:International Journal of Psychiatry in Clinical Practice

Author:

Kasper Siegfried

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health

Link

http://www.tandfonline.com/doi/pdf/10.1080/13651500410005504

Reference15 articles.

1. Residual Symptoms in Depression

2. Selectivity of SSRIs: individualising patient care through rational treatment choices

3. Kasper S, Carlsson A (2001) Selective serotonin reuptake inhibitors 1990 -2000. A decade of developments. Lundbeck publishing, Copenhagen, Denmark.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness, safety and adherence to therapy with Elicea Q-Tab in real clinical practice;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023

2. Superiority of escitalopram to paroxetine in the treatment of depression;European Neuropsychopharmacology;2009-04

3. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study;Psychopharmacology;2007-01-19

4. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram;Psychopharmacology;2006-09-06

5. Serotonin Reuptake Inhibitors: The Corner Stone in Treatment of Depression for Half a Century – A Medicinal Chemistry Survey;Current Topics in Medicinal Chemistry;2006-09-01